US company financials from SEC filings
Revenue, profit, cash flow and recent filings for 188 companies with US stock tickers, from the reports they file with the SEC (EDGAR): several fiscal years from annual 10-K reports, where the company files them. Financial data only; no stock prices.
Highlights
Just filed
Newest SEC filingsFastest revenue growth
Latest fiscal year · revenue ≥ $1BHighest net margin
Latest fiscal year · revenue ≥ $1BCompany lists
Highest revenue growth in the latest fiscal year, among companies with at least $100M of revenue. · Health care
Showing 1–9 of 9 companies
| Company | Sector | Revenue (FY) | YoY | Net income | Net margin | ROE | F-Score | 5y revenue | Last filing |
|---|---|---|---|---|---|---|---|---|---|
| ISRGINTUITIVE SURGICAL INCNew 8-K: Filed an 8-K current report in the last 7 days. | Health care | $10.1B | up 20.51% | $2.86B | 28.4% | 16.7% | — | 8-K | |
| MCKMCKESSON CORP | Health care | $403B | up 12.36% | $4.76B | 1.2% | — | 6/9 | 8-K | |
| SYKSTRYKER CORP | Health care | $25.1B | up 11.16% | $3.25B | 12.9% | 15.1% | 6/9 | 10-Q | |
| VRTXVERTEX PHARMACEUTICALS INC / MA | Health care | $12B | up 8.90% | $3.95B | 32.9% | 22.5% | — | 10-Q | |
| MDTMedtronic plc | Health care | $36.4B | up 8.43% | $4.8B | 13.2% | 9.8% | 7/9 | 8-K | |
| HCAHCA Healthcare, Inc.New 8-K: Filed an 8-K current report in the last 7 days. | Health care | $75.6B | up 7.08% | $6.78B | 9.0% | — | — | 8-K | |
| ABTABBOTT LABORATORIES | Health care | $44.3B | up 5.67% | $6.52B | 14.7% | 13.1% | 6/9 | 8-K | |
| BMYBRISTOL MYERS SQUIBB CO | Health care | $48.2B | down 0.22% | $7.05B | 14.6% | 40.5% | 8/9 | 10-Q | |
| PFEPFIZER INCNew 8-K: Filed an 8-K current report in the last 7 days. | Health care | $62.6B | down 1.65% | $7.77B | 12.4% | 8.9% | 6/9 | 8-K |
Sectors are grouped by CoinFlip from the SEC's SIC industry code.
Source: SEC EDGAR · Last updated:
Ver en españolNot investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.